Ingalls & Snyder LLC Agenus Inc Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$2.69 - $5.25 $538,000 - $1.05 Million	-200,000 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$2.51 - $3.73 $501,999 - $746,000	200,000 New	200,000 $594,000
Q2 2018 Aug 10, 2018	SELL	$2.26 - $4.65 $33,222 - $68,355	-14,700 Closed	0 $0
Q4 2017 Jan 19, 2018	SELL	$3.26 - $4.78 $1,304 - $1,912	-400 Reduced 2.65%	14,700 $48,000
Q3 2017 Oct 20, 2017	BUY	$3.48 - $4.44 $52,548 - $67,044	15,100	15,100 $67,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.